Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 21;10(11):985.
doi: 10.3390/diagnostics10110985.

Is Ultrasound an Accurate Alternative for Mammography in Breast Cancer Screening in an Asian Population? A Meta-Analysis

Affiliations
Review

Is Ultrasound an Accurate Alternative for Mammography in Breast Cancer Screening in an Asian Population? A Meta-Analysis

Jing Wang et al. Diagnostics (Basel). .

Abstract

In Asian countries, ultrasound has been proposed as a possible alternative for mammography in breast cancer screening because of its superiority in dense breasts, accessibility and low costs. This research aimed to meta-analyze the evidence for the diagnostic performance of ultrasound compared to mammography for breast cancer screening in Asian women. PubMed, Web of Science, and China National Knowledge Infrastructure databases were searched for studies that concurrently compared mammography and ultrasound in 2000-2019. Data extraction and risk of bias were performed according to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA) statement. The primary outcome was the sensitivity and specificity. Bivariate random models were used to generate pooled estimates of diagnostic parameters and 95% confidence intervals (95% CI). In total, 4424 studies were identified of which six studies met the inclusion criteria with a sample size of 124,425 women. The pooled mean prevalence of the included studies was 3.7‱ (range: 1.2-5.7‱). The pooled sensitivity of mammography was significantly higher than that of ultrasound (0.81 [95% CI 0.71-0.88] versus 0.65 [95% CI 0.58-0.72], p = 0.03), but no significant differences were found in specificity (0.98 [95% CI: 0.94-1.00] versus 0.99 [95% CI: 0.97-1.00], p = 0.65). In conclusion, based on the currently available data on sensitivity alone, there is no indication that ultrasound can replace mammography in breast cancer screening in Asian women.

Keywords: breast neoplasms; mammography; mass screening; meta-analysis; ultrasonography.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Flow chart of the literature search.
Figure 2
Figure 2
Risk of bias and applicability concerns: review authors’ judgements about each domain presented as a percentage across the included studies.
Figure 3
Figure 3
Forest plot of the sensitivity (left) and specificity (right) of mammography (top) and ultrasound (bottom) breast cancer screening in Asian women.

Similar articles

Cited by

References

    1. DeSantis C.E., Bray F., Ferlay J., Lortet-Tieulent J., Anderson B.O., Jemal A. International Variation in Female Breast Cancer Incidence and Mortality Rates. Cancer Epidemiol. Biomark. Prev. 2015;24:1495–1506. doi: 10.1158/1055-9965.EPI-15-0535. - DOI - PubMed
    1. Fan L., Goss P.E., Strasser-Weippl K.K. Current Status and Future Projections of Breast Cancer in Asia. Breast Care. 2015;10:372–378. doi: 10.1159/000441818. - DOI - PMC - PubMed
    1. Sung H., Rosenberg P.S., Chen W.-Q., Hartman M., Lim W.-Y., Chia K.S., Mang O.W.-K., Chiang C.-J., Kang D., Ngan R.K.-C., et al. Female Breast Cancer Incidence Among Asian and Western Populations: More Similar Than Expected. J. Natl. Cancer Inst. 2015;107:djv107. doi: 10.1093/jnci/djv107. - DOI - PMC - PubMed
    1. Moss S.M., Wale C., A Smith R., Evans A., Cuckle H., Duffy S.W. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years’ follow-up: A randomised controlled trial. Lancet Oncol. 2015;16:1123–1132. doi: 10.1016/S1470-2045(15)00128-X. - DOI - PubMed
    1. Tabár L., Yen M.-F., Vitak B., Chen H.-H.T., Smith R.A., Duffy S.W. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003;361:1405–1410. doi: 10.1016/S0140-6736(03)13143-1. - DOI - PubMed

LinkOut - more resources